JPRN-UMIN000017715招募中1 期
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancer - Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Non curative operation 2)Active concomitant malignancy 3)History of severe anaphylaxies 4)Severe complications, such as heart failure, renal failure, liver failure, watery diarrhea, paresis of intestine, ileus and severe diabetes mellitus 5)With the jaundice or cirrhosis 6)Active infection 7)Pregnant or pregnant possibility 8)Severe mental disorder 9)Inappropriate
研究者
相似试验
已完成
2 期
Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancerpancreatic cancerJPRN-UMIN000002791Kyoto University Hospital35
已完成
1 期
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40
招募中
1 期
Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.JPRN-UMIN000006208The University of Tokyo Hospital. Department of surgical oncology.39
进行中（未招募）
不适用
Phase I/II-Studie zur neoadjuvanten Chemotherapie mit nicht-pegyliertem liposomalem Doxorubicin, Paclitaxel und Lapatinib bei Patientinnen mit HER2-überexprimierenden, primärem MammakarzinomeEUCTR2007-000924-42-DESana Klinikum Lichtenberg
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50